KRSNAANSEKrsnaa Diagnostics LimitedMediumNeutral
Announced Fri, 17 Apr · 16:47 IST

Krsnaa Diagnostics Limited has informed the Exchange about General Updates

Multiple Ind Directors ResignedManagement Changes View source PDF

KRSNAA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.0%1-day move
₹625.00
prior close
₹627.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-0.9-1.4-2.4-2.0-2.8-2.1-4.2-4.3-6.4-7.2-9.3-14.4-12.2
Up moveDown movePending
AI summary

Krsnaa Diagnostics' Board meeting held on April 17, 2026 approved multiple leadership changes. Two new Independent Directors were appointed: Mr. Raju Venkatraman (serial entrepreneur with diagnostics/healthcare background) and Ms. Lilian Jessie Paul (marketing strategist with experience at PolicyBazaar, Bajaj). Mr. Chetan Desai was reappointed for a 5-year term as Independent Director. Mr. Chandra Prakash Singh was appointed as Interim CFO with 28 years of finance experience. Three directors completed their tenure and ceased to be directors: Ms. Pallavi Bhatevara (Whole-time Director), Mr. Rajiva Ranjan Verma, and Ms. Chhaya Palrecha (both Independent Directors). All committees were reconstituted with new members effective April 25, 2026.

Likely market impact

The board has completed a comprehensive refresh with three directors exiting and two new independent directors joining, bringing fresh expertise in diagnostics, marketing, and governance. The interim CFO appointment indicates an open position at the CFO level pending a permanent hire. Overall, these appear to be routine governance changes rather than cause for concern.